Home › Funds › Parkman Healthcare Partners LLC › ASMB

Parkman Healthcare Partners LLC position in ASMB

ASSEMBLY BIOSCIENCES INC · Health Care

Parkman Healthcare Partners LLC reported holding 796,256 shares of ASMB (ASSEMBLY BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$18.7M, representing 1.69% of its reported portfolio and ranking #16 among its reported holdings. Parkman Healthcare Partners LLC has disclosed ASMB holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)796.26K sh
Reported value held$18.70M
Portfolio Weight1.69%
First reportedQ3 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's ASMB position evolved

Parkman Healthcare Partners LLC first disclosed a stake in ASMB in Q3 2025 at 250,981 shares (US$6.4M). The position peaked in Q2 2026 at 721,181 shares, worth US$19.8M. Across 5 filings, Parkman Healthcare Partners LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 796,256 shares valued at US$18.7M — an increase of 75,075 shares quarter over quarter.. Notable position changes include a 65% increase in Q1 2026 (shares were roughly flat over the following quarter), a 75% increase in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 250.98K $6.43M New
Q4 2025 249.36K $8.48M Reduce
Q1 2026 411.23K $11.41M Add
Q2 2026 721.18K $19.82M Add
Q3 2026 796.26K $18.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASMB and 13F data

ASMB (ASSEMBLY BIOSCIENCES INC) is a Health Care company. 55 other funds we track also report a position in ASMB — the largest reported positions include GILEAD SCIENCES, INC. (US$116.9M), Farallon Capital Management (US$44.1M), Commodore Capital LP (US$38.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASMB

All ASMB fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held ASMB?

Parkman Healthcare Partners LLC has disclosed ASMB holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Parkman Healthcare Partners LLC's current position in ASMB?

As of Q3 2026, Parkman Healthcare Partners LLC holds 796.26K shares of ASMB (ASSEMBLY BIOSCIENCES INC), valued at $18.70M, representing 1.69% of its reported portfolio and ranking #16.

Has Parkman Healthcare Partners LLC been buying or selling ASMB?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in ASMB. The position peaked in Q2 2026 at 721.18K shares.

Which other funds hold ASMB?

Other major institutional holders of ASMB include GILEAD SCIENCES, INC., Farallon Capital Management, Commodore Capital LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.